Duane Morris Class Action Review - 2023 - Report - Page 383
#
CASE TITLE
ATTORNEYS’
FEE AWARD
LOCATION &
APPROVAL
DATE
TYPE OF CASE
7
In Re National
Prescription Opiate
Litigation
$398 Million
Opioid Class Action
Defendant Janssen
U.S. District
Court for the
Northern District
of Ohio
Case No. 17-MD-02804
Mar. 30, 2022
8
10
Defendant Teva
U.S. District
Court for the
Northern District
of Ohio
Case No. 17-MD-02804
Nov. 22, 2022
In Re National
Prescription Opiate
Litigation
In Re National
Prescription Opiate
Litigation Defendant
AbbVie/Allergan
$366 Million
$207 Million
Case No. 17-MD-02804
11
In Re Twitter Inc.
Securities Litigation
U.S. District
Court for the
Northern District
of Ohio
Opioid Class Action
Opioid Class Action
Nov. 22, 2022
$182 Million
Case No. 16-CV-531
U.S. District
Court for the
Northern District
of California
Securities Fraud Class
Action
Nov. 17, 2022
12
City Of Long Beach, et al.
v. Monsanto Co.
$98 Million
U.S. District
Clean Water Act Class
Court for the
Action
Central District of
California
Case No. 16-CV-3493
Nov. 19, 2022
13
In Re Ranbaxy Generic
Drug Application
$97 Million
U.S. District
Court for the
District of
Massachusetts
Case No. 19-MD-02878
RICO/Fraud Class
Action
Sep. 19, 2022
14 Laurent, et al. v.
PriceWaterhouse Coopers
LLP
$89 Million
U.S. District
Court for the
Southern District
of New York
Case No. 06-CV-2280
ERISA Class Action
Nov. 1, 2022
382
© Duane Morris LLP 2023
Duane Morris Class Action Review – 2023
